Citeline Podcasts

During this episode, Barnaby Pickering is joined by Rollie Carlson, CEO of Immunexpress, developer of Septicyte, a test for sepsis, Mark McDonough, CEO of ChromaCode, a company developing multiple blood-based tests for cancer diagnosis and treatment, with its first being in non-small cell lung cancer, and Lishan Aklog, CEO of Lucid Diagnostics, who have developed a cell-collection method that aims to bring forward the stage at which oesophageal cancer can be diagnosed.

The group discuss the companies’ products and why they are transformative, as well as the upcoming regulatory and commercial hurdles awaiting diagnostics companies.

Xiaodong Wang of major Chinese pharma firm BeiGene and China's National Institute of Biological Sciences shares views on China biotech innovation, BeiGene and next big thing with Scrip's Brian Yang.

HBW Insight continues its conversation with The Exponential Club’s Nick Tate. In this episode, we discuss what the future of consumer health might actually look like, covering a lot of ground from nudge-based health insurance platforms to digital products that may supplement or even replace traditional medicines. We also talk about the promise and limitations of at-home testing for furthering personalisation, and how to navigate partnerships with tech-specialists large and small to help accelerate digital transformation plans.

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the biggest drug launches expected in 2024; Roche’s Pharma CEO talks about growth momentum; 10 pivotal studies to look out for this year; the obesity market now and in future; and what does 2024 hold for transformative technology in biopharma.

https://scrip.citeline.com/SC149742/Quick-Listen-Scrips-Five-MustKnow-Things

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and demos of some of the most innovative tech seen at CES 2024 in Las Vegas. Hannah Daniel dives into the latest developments in the intellectual property dispute between Apple and Masimo over blood oxygen sensors in the newer Apple Watch models.

Medtech Insight articles addressing topics discussed in this episode:

Dexcom COO On Stelo CGM Plans, Apple Watch Developments, And Why Non-Invasive Glucose Monitoring Still Leaves Much To Desire

Abbott Lingo Leaders On Consumer Biowearable Outlook: ‘A Lot Of Appetite For Glucose As A Biomarker For Your Health’

CES Roundup: Holoportation, Empathic Robot, Aging Suit, Bionic Prosthetic Arm, Headband For Better Sleep

Roundup: AI-Powered Assistive Hearing Devices Scream With Personalization; Femtech From Baby Makers To Menopause

Apple Watches Are Back On The US Market

News We’re Watching: Apple/Masimo Patent Fight Update

Apple Drops Pulse Oximeter Features To Subvert Import Ban

In the latest episode of the In Vivo podcast, Edwin Stone, CEO of UK-based Cellular Origins, talks about how robotics can increase access to safe cellular therapies. The type of biology-agnostic robotics his company develops can help companies scale up cell manufacturing while lowering the cost of production.

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s pipeline refresh; J&J’s selective pharma M&A approach; silver lining for Gilead’s Trodelvy miss?; paying for obesity drugs; and the story behind Vertex and CRISPR’s gene therapy breakthrough.

https://scrip.citeline.com/SC149699/Quick-Listen-Scrips-Five-MustKnow-Things

Medtech Insight regulatory reporter Hannah Daniel speaks to Sanjay Voleti, AliveCor’s chief business officer, about his company’s patent infringement case against Apple and what it’s like to take on a tech giant over intellectual property.

Pink Sheet reporters and editor discuss FDA Principal Deputy Commissioner Janet Woodcock’s place in the pantheon of FDA leaders (:27), an agency meeting with stakeholders on puberty blockers (23:55), and a new boxed warning for CAR-T therapies (35:42).

More On These Topics From The Pink Sheet

Immortalizing Janet Woodcock: https://pink.citeline.com/PS149666/Immortalizing-Janet-Woodcock

On Puberty Blockers, FDA Is In ‘Listen Only’ Mode – For Now: https://pink.citeline.com/PS149679/On-Puberty-Blockers-FDA-Is-In-Listen-Only-Mode--For-Now

CAR-Ts Getting Boxed Warning On Secondary Malignancies Despite Sponsor Causation Questions: https://pink.citeline.com/PS149673/CAR-Ts-Getting-Boxed-Warning-On-Secondary-Malignancies-Despite-Sponsor-Causation-Questions

Kite’s Tecartus Boxed Warning Will More Closely Resemble Other CAR-Ts After FDA Changes Course: https://pink.citeline.com/PS149680/Kites-Tecartus-Boxed-Warning-Will-More-Closely-Resemble-Other-CAR-Ts-After-FDA-Changes-Course

In this discussion, Dr. Fleming provides expert insight to questions about treating LBCL in elderly patients and those with comorbidities.